Memgen, Inc. — Form D/A

Memgen, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2021-12-14. The offering totals $10.0M, of which $9.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-12-14
• Form: D/A
• Accession: 0001760644-21-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $9.8M
• Remaining: $233K
• Investors: 60
• Date of first sale: 2021-11-30
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-424681

Issuer

• Name: Memgen, Inc.
• CIK: 0001760644
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 12 GREENWAY PLAZA, HOUSTON, TX, 77046
• Phone: 8325485651

Officers, directors & promoters (12)

Other filings by this issuer (9)

More

• CIK 1760644 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search